X-103063225-G-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_018476.4(BEX1):c.50C>A(p.Ala17Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,209,237 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A17V) has been classified as Likely benign.
Frequency
Consequence
NM_018476.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000270 AC: 3AN: 111234Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.0000164 AC: 3AN: 182447 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1098003Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 1AN XY: 363359 show subpopulations
GnomAD4 genome AF: 0.0000270 AC: 3AN: 111234Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33450 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.50C>A (p.A17D) alteration is located in exon 3 (coding exon 1) of the BEX1 gene. This alteration results from a C to A substitution at nucleotide position 50, causing the alanine (A) at amino acid position 17 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at